Strong Operating Profit, Up 8% YoY to $400 millionPowered by Same-Store Sales Growth, Accelerated New Store Openings and Margin ExpansionAchieved 11 ...
A recent study reveals global regulatory inconsistencies in biosimilars, urging convergence to enhance access and savings for patients and health care systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback